Helicobacter pylori recrudescence and its influencing factors
- PMID: 31536675
- PMCID: PMC6850920
- DOI: 10.1111/jcmm.14682
Helicobacter pylori recrudescence and its influencing factors
Abstract
Helicobacter pylori (H pylori) is known as one of the most common infectious pathogens, with high infection and recurrence rates worldwide. The prevalence of H pylori is up to 90% in developing countries, while the annual recurrence rate is much higher than that in developed countries. Recurrence can occur either by recrudescence or reinfection. Compared with reinfection, the time window for recrudescence is generally shorter, followed by the recurrence of H pylori-associated diseases in the short-term. Many factors are involved in the H pylori reinfection, such as the prevalence of H pylori infection, living conditions and economic development, health conditions and so forth. Previous studies focused less on H pylori recrudescence. Therefore, the influencing factors for H pylori recrudescence needed further exploration. This study reviewed the recrudescence of H pylori infection and its influencing factors.
Keywords: Helicobacter pylori; colonization; influencing factors; recrudescence.
© 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Conflict of interest statement
The authors declare that they have no conflicts of interest concerning this study.
Figures

Similar articles
-
Reinfection versus recrudescence in Helicobacter pylori infection.Aliment Pharmacol Ther. 1997 Apr;11 Suppl 1:55-61. doi: 10.1046/j.1365-2036.11.s1.10.x. Aliment Pharmacol Ther. 1997. PMID: 9146791 Review.
-
Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection.Helicobacter. 2014 Jun;19(3):202-6. doi: 10.1111/hel.12117. Epub 2014 Mar 11. Helicobacter. 2014. PMID: 24612156
-
H pylori recurrence after successful eradication.World J Gastroenterol. 2008 Mar 14;14(10):1477-8. doi: 10.3748/wjg.14.1477. World J Gastroenterol. 2008. PMID: 18330934 Free PMC article. Review.
-
Recurrence of infection and diversity of Helicobacter pylori strains in an adult population in Mexico treated with empirical standard triple therapy.Rev Esp Enferm Dig. 2017 Nov;109(11):749-756. doi: 10.17235/reed.2017.4994/2017. Rev Esp Enferm Dig. 2017. PMID: 29072083
-
High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection.Am J Gastroenterol. 2003 Nov;98(11):2395-402. doi: 10.1111/j.1572-0241.2003.07708.x. Am J Gastroenterol. 2003. PMID: 14638339
Cited by
-
The impact of diet, exercise, and sleep on Helicobacter pylori infection with different occupations: a cross-sectional study.BMC Infect Dis. 2024 Jul 11;24(1):692. doi: 10.1186/s12879-024-09505-8. BMC Infect Dis. 2024. PMID: 38992594 Free PMC article.
-
Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation.eGastroenterology. 2024 Dec 23;2(4):e100099. doi: 10.1136/egastro-2024-100099. eCollection 2024 Oct. eGastroenterology. 2024. PMID: 39944265 Free PMC article. Review.
-
The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?Int J Environ Res Public Health. 2023 Feb 18;20(4):3640. doi: 10.3390/ijerph20043640. Int J Environ Res Public Health. 2023. PMID: 36834334 Free PMC article. Review.
-
[Combined detection of Helicobacter pylori 16S rRNA and cagA gene in saliva specimens using multiplex PCR].Nan Fang Yi Ke Da Xue Xue Bao. 2021 Dec 20;41(12):1816-1821. doi: 10.12122/j.issn.1673-4254.2021.12.09. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 35012913 Free PMC article. Chinese.
-
A Mini-review on Helicobacter pylori with Gastric Cancer and Available Treatments.Endocr Metab Immune Disord Drug Targets. 2024;24(3):277-290. doi: 10.2174/1871530323666230824161901. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 37622707 Review.
References
-
- Zeng M, Mao XH, Li JX, et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double‐blind, placebo‐controlled, phase 3 trial. Lancet. 2015;386:1457‐1464. - PubMed
-
- Sarem M, Corti R. Role of Helicobacter pylori coccoid forms in infection and recrudescence. Gastroenterol Hepatol. 2016;39:28‐35. - PubMed
-
- Wang X, Zhao X, Lu X, Li Y. Relationship between Helicobacter pylori infection and hematologic system diseases. Chin J Gastroenter Hepatol. 2018;27:134‐137.
-
- Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018;23(Suppl 1):e12514. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical